Leapcure

Leapcure helps patients access clinical trial treatment when existing care can’t meet their needs. We have saved over 60 years of research across 42 countries and played a part in saving thousands of lives with our COVID-19 work in the past 18 months. We are a values-based, autonomous, fully remote company, with global team members based in seven countries.

We work closely with thousands of global patient advocacy groups/health nonprofits to connect patients with research and are a leading voice for DEI (Diversity, Equity, and Inclusion) in research. Our diverse community partnerships accelerated awareness and helped Moderna obtain their Phase 3 vaccine approval, saving roughly one month from their approval timeline. In addition, Leapcure is paving the path for more inclusive clinical trial design and is committed to ensuring that research representation is culturally educated.